Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Verastem Oncology Announces U.S. IND Clearance of VS-7375, Oral KRAS G12D (ON/OFF) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors
-
Joby Aviation to Report First Quarter 2025 Financial Results
-
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 7, 2025
-
ACV to Report First Quarter 2025 Financial Results on May 7, 2025
-
Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting
-
Highwoods Declares Quarterly Dividends
-
Concerned Shareholders of Aurinia Pharmaceuticals Announce Their Intention to Withhold Support for CEO Peter Greenleaf at 2025 Annual Meeting
-
SunCoke Energy, Inc. Announces First Quarter 2025 Earnings Date
-
Knight-Swift Transportation Holdings Inc. Announces Results for First Quarter 2025
-
AerSale Announces Date for First Quarter 2025 Earnings Release Conference Call
-
Biote Schedules First Quarter 2025 Financial Results Release and Conference Call
-
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
-
Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
-
Getty Realty Corp. Announces First Quarter 2025 Results
-
Dragonfly Energy Announces First Quarter 2025 Preliminary Net Sales and Adjusted EBITDA
-
MARA Schedules Conference Call for First Quarter 2025 Financial Results
-
Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event
-
Beyond Meat® to Report First Quarter 2025 Financial Results on May 7, 2025
-
RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025
-
Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred Units
-
Toast Announces Release Date of First Quarter 2025 Financial Results
-
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th
-
ACV to Report First Quarter 2025 Financial Results on May 7, 2025
-
Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025
-
BBSI Sets First Quarter 2025 Conference Call for Wednesday, May 7, 2025, at 5:00 p.m. ET
-
Remitly to Report First Quarter Financial Results on May 7, 2025
-
OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025
-
Edge Delta Launches an MCP Server, Ushering in a New Era of AI-Driven Observability and Security Workflows
-
Columbia Banking System to Acquire Pacific Premier Bancorp, Expanding the Premier Business Bank in the West
-
Eguana Announces Anticipated Late Filing of Annual Financial Statements
-
NPWR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that NET Power Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
SVVC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Firsthand Technology Value Fund, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
BBAI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BigBear.ai Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Bakkt INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bakkt Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
MGPI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MGP Ingredients, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Actinium Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
EU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that enCore Energy Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
TFII INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TFI International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
FLNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fluence Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
APP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AppLovin Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Credit Acceptance Recognized with Multiple 2025 Top Workplaces Spring Culture Excellence Awards
-
Credit Acceptance Announces Timing of First Quarter 2025 Earnings Release and Webcast
-
Goosehead Insurance, Inc. Announces First Quarter 2025 Results
-
Churchill Downs Incorporated Reports 2025 First Quarter Results
-
SEI Reports First-Quarter 2025 Financial Results
-
Bankwell Financial Group Reports Operating Results for the First Quarter, Declares Second Quarter Dividend
-
TI reports first quarter 2025 financial results and shareholder returns
